信邦制药(002390.SZ)：上半年净利润1.07亿元 拟10派0.3元

Group 1 - The core viewpoint of the article is that Xinfang Pharmaceutical (002390.SZ) reported a decline in both revenue and net profit for the first half of 2025 compared to the same period last year [1] Group 2 - The company achieved operating revenue of 2.845 billion yuan, a year-on-year decrease of 6.62% [1] - The net profit attributable to shareholders of the listed company was 107 million yuan, down 6.69% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was also 107 million yuan, reflecting a 7.16% decline year-on-year [1] - The basic earnings per share were 0.0565 yuan [1] - The company proposed a cash dividend of 0.30 yuan (including tax) for every 10 shares to all shareholders [1]